Tibet Rhodiola Pharmaceutical Holding Co. Class A (600211.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 13.71B |
| Enterprise Value | 12.89B |
| P/E Ratio | 11.85 |
| PEG Ratio | -9.15 |
| Price/Sales Ratio | 4.04 |
| Price/Book Ratio | 2.94 |
| Enterprise/Revenue | 3.93 |
| Enterprise/EBITDA | 10.81 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.34 |
| Operating Margin | 0.29 |
AD
Management Effectiveness
| Return On Assets | 0.15 |
| Return On Equity | 0.26 |
Income Statement
| Revenue | 2.95B |
| Revenue/Share | 9.06 |
| Gross Profit | 2.74B |
| EBITDA | 1.13B |
| Net Income | 937.93M |
| Diluted EPS | 2.91 |
Balance Sheet
| Total Cash | 3.74B |
| Total Cash/Share | 11.75 |
| Total Debt | 1.17B |
| Total Debt/Equity | 0.3 |
| Current Ratio | 2.87 |
| Book Value Per Share | 13.27 |
Price History
| 52-Week Change | -20.14 |
| 52-Week High | 48.99 |
| 52-Week Low | 34.8 |
| Moving Average 50 Days | 37.31 |
| Moving Average 200 Days | 39.72 |
Statistics
| Average Volume | 3.69M |
| Shares Outstanding | 322.32M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 2.02 |
| Trailing Annual Dividend Yield | 5.6 |
| Payout Ratio | 1.21 |
| Last Split Factor | 13:10 |
| Last Split Date | April 30, 2024 |
AD
